You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 11, November 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 27TH SCIENTIFIC MEETING OF THE INTERNATIONAL CARDIOVASCULAR SOCIETY, NASHVILLE, TENN, JUNE 28-30, 1979-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Membrane vs Bubble Oxygenators

A Prospective Study of 52 Patients

George L. Hicks, MD; Hans H. J. Zwart, MD; Richard A. DeWall, MD

Arch Surg. 1979;114(11):1285-1287.


Abstract

• Controversy continues about the oxygenator preferable for cardiopulmonary bypass (CPB). This prospective study was undertaken in 52 patients undergoing coronary bypass surgery. Oxygenators were alternated each case between model Q-100, Bentley Laboratories Inc, Irvine, Calif, and Travenol Membrane Oxygenator (TMO), Travenol Laboratories Inc, Deerfield, Ill. The Q-100 group required higher CPB O2 flows, but Po2 levels during CPB were similar for both groups. Heparin sodium dosage and activated clotting, bleeding, prothrombin, and partial thromboplastin times were identical in both groups. Blood loss and platelet reduction after CPB were also similar. Postoperative complications in the Q-100 group included one myocardial infarction, and one neurological problem. The TMO group had no myocardial infarctions and one neurological problem. The membrane oxygenator took nine minutes longer to set up and was $63 more expensive to purchase. Blood trauma during CPB was less with the membrane oxygenator (lower plasma hemoglobin level), but we conclude that both oxygenators performed adequately during clinical use in open heart surgery.

(Arch Surg 114:1285-1287, 1979)



Author Affiliations

From the Division of Cardiothoracic Surgery, Wright State University, Kettering Medical Center, Dayton, Ohio.


Footnotes

Accepted for publication Aug 6, 1979.

Read before the 27th scientific meeting of the International Cardiovascular Society, Nashville, Tenn, June 28, 1979.

Reprint requests to 111 W First St, Suite 918, Dayton, OH 45402 (Dr Hicks).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
The Society of Thoracic Surgeons Blood Conservatio et al.
Ann. Thorac. Surg. 2007;83:S27-S86.
ABSTRACT | FULL TEXT  

In vitro evaluation of the Mera Silox-S 0.5 and 0.8 m2 silicone hollow-fibre membrane oxygenator for use in neonatal ECMO
Rais-Bahrami et al.
Perfusion 1992;7:315-320.
ABSTRACT  

Neutrophil function and cardiopulmonary bypass in humans. The effects of glucose and non-glucose containing bypass pump priming fluids
Conroy et al.
Perfusion 1986;1:103-116.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.